"Cardiology"

During the past decade, Interventional Cardiac Consultants conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interventional Cardiac Consultants" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Interventional Cardiac Consultants" are "Cardiovascular Disease" (3 trials), "ASCVD" (1 trials), "Cardiovascular Diseases" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Interventional Cardiac Consultants" in a lesser frequency.

Most popular intervention types in "Interventional Cardiac Consultants" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Intense Education Intervention" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Interventional Cardiac Consultants" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Interventional Cardiac Consultants". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Interventional Cardiac Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Interventional Cardiac Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".